期刊
WORLD JOURNAL OF GASTROENTEROLOGY
卷 28, 期 12, 页码 1220-1225出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v28.i12.1220
关键词
Colorectal mucus; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Colorectal cancer; Faecal calprotectin
Colonoscopy is the gold standard for diagnosing IBD and CRC, but it is invasive and carries risk. Non-invasive methods are limited, and research suggests that non-invasively obtained colorectal mucus may serve as a screening and diagnostic tool for IBD and CRC.
Colonoscopy is currently the gold standard for diagnosis of inflammatory bowel disease (IBD) and colorectal cancer (CRC). This has the obvious drawback of being invasive as well as carrying a small risk. The most widely used non-invasive approaches include the use of faecal calprotectin in the case of IBD and fecal immunochemical test in the case of CRC. However, the necessity of stool collection limits their acceptability for some patients. Over the recent years, there has been emerging data looking at the role of non-invasively obtained colorectal mucus as a screening and diagnostic tool in IBD and CRC. It has been shown that the mucus rich material obtained by self-sampling of anal surface following defecation, can be used to measure various biomarkers that can aid in diagnosis of these conditions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据